Critical Pressure

United Kingdom
Cambridge, England, United Kingdom, CB22 3AT

Company profile

Critical Pressure company profile

Critical Pressure is a provider of drugs designed to treat to treat vascular dysfunction and shock. The company's technology has the potential to change clinical practice without the potentially harmful effects of excess fluid administration and toxicities associated with the currently available catecholamine-based vasoactive agents, providing the possibility of supportive therapy during the critical period of haemodynamic compromise.

Business identity

Contact email
[email protected]
Phone number
+44 (0)1223 834510
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2017-01-01, Year

Headquarters

Postal code
CB22 3AT
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$13.2M
Last funding
Series A / $13.2M / 2017-11-16
Last equity funding
Series A / $13.2M
Investors
1
Lead investors
1
Founders
1

Founders and investors

Founders

James M. Leiper

Lead investors

Medicxi

Investors

Medicxi